Fibroblast Activation Protein-a and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression

Home > Science Hub > Fibroblast Activation Protein-a and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression
Back to the list

August 5, 2024

You might also be interested by

Videos

Poster Video: Induction of an effective immune response is an essential element of cancer immunotherapy

September 2, 2025

Histopathology

More info

Posters

Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

March 5, 2025

Histopathology

More info

Scientific Publications

Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer

January 27, 2025

Histopathology

More info

Posters

Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in Non-Small Cell Lung Cancer, Colorectal Cancer, and Urothelial Cancer

November 7, 2024

Histopathology

More info